Skip to content

The anesthesia effect and adverse reactions of intercostal nerve block for breast tumor surgery

Horner's syndrome following intercostal nerve block in anterior approach in local breast lumpectomy: a prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019759
Enrollment
Unknown
Registered
2018-11-27
Start date
2017-09-01
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast tumor

Interventions

1:intercostal nerve block in anterior approach with 0.375% ropivacaine

Sponsors

Fudan University Shanghai Cancer Centre, Department of Oncology, Shanghai Medical College Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
17 Years to 87 Years

Inclusion criteria

Inclusion criteria: Women scheduled for breast lumpectomy under ICB and classified as ASA (American Society of Anesthesiologists Physical Status) physical status I-III were eligible for the study.

Exclusion criteria

Exclusion criteria: 1) bilateral ICB; 2)had allergic history of local anesthetics; 3)infection of puncture sites; 4)neuropathy such as idiopathic facial paralysis; 5)history of stroke, transient ischemic attack; 6)coagulopathy, anticoagulation; 7)eye surgery; 8)ocular diseases including glaucoma and cataracts.

Design outcomes

Primary

MeasureTime frame
body mass index;Age;the dose of ropivacaine;Intercostal space of ICB;The location of the mass (Left breast or right breast);

Secondary

MeasureTime frame
other adverse events;Duration of ICB;Duration of the surgery (min);

Countries

China

Contacts

Public ContactChanghong Miao

Department of Anesthesiology, Fudan University Shanghai Cancer Centre, Department of Oncology, Shanghai Medical College Fudan University Shanghai 200032, China

miaochh@aliyun.com+86 18121299310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026